Wird geladen...
Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
BACKGROUND: Rebamipide with mucin secretagogue activity was recently approved for the treatment of dry eye. The efficacy and safety in the treatment of rebamipide were shown in two pivotal clinical trials. It was the aim of this study to evaluate the effect of 2 % rebamipide ophthalmic suspension in...
Gespeichert in:
| Veröffentlicht in: | BMC Ophthalmol |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4456696/ https://ncbi.nlm.nih.gov/pubmed/26048396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-015-0040-0 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|